CN Patent

CN1376166A — 降低血液葡萄糖水平的肽

Assigned to Sealand Pharmaceutical Assets Of Finance Cos · Expires 2002-10-23 · 24y expired

What this patent protects

本发明涉及稳定性增加且可用于治疗过高血糖水平的新的肽偶联物。

USPTO Abstract

本发明涉及稳定性增加且可用于治疗过高血糖水平的新的肽偶联物。

Drugs covered by this patent

Patent Metadata

Patent number
CN1376166A
Jurisdiction
CN
Classification
—
Expires
2002-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Sealand Pharmaceutical Assets Of Finance Cos
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.